Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Dr. Reddy's Laboratories Ltd ADR (RDY)
Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,322,916
  • Shares Outstanding, K 166,857
  • Annual Sales, $ 2,992 M
  • Annual Income, $ 548,000 K
  • 60-Month Beta 0.55
  • Price/Sales 3.78
  • Price/Cash Flow 16.19
  • Price/Book 3.74
Trade RDY with:

Options Overview Details

View History
  • Implied Volatility 18.92% ( -9.31%)
  • Historical Volatility 17.62%
  • IV Percentile 21%
  • IV Rank 42.31%
  • IV High 44.53% on 01/19/23
  • IV Low 0.13% on 04/12/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 292
  • Open Int (30-Day) 316

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.87
  • Number of Estimates 1
  • High Estimate 0.87
  • Low Estimate 0.87
  • Prior Year 0.91
  • Growth Rate Est. (year over year) -4.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.72 +6.83%
on 11/03/23
69.06 -1.43%
on 11/22/23
+3.02 (+4.64%)
since 10/27/23
3-Month
63.72 +6.83%
on 11/03/23
70.29 -3.16%
on 09/15/23
-1.69 (-2.42%)
since 08/29/23
52-Week
51.11 +33.18%
on 12/27/22
73.17 -6.97%
on 08/23/23
+13.51 (+24.76%)
since 11/28/22

Most Recent Stories

More News
2 overlooked stocks that crushed earnings but traded lower

As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results

BMY : 48.94 (+0.04%)
WHR : 110.07 (+1.61%)
BAC : 30.33 (+2.71%)
DB : 12.40 (+1.97%)
HSBC : 38.05 (-1.40%)
NVS : 96.75 (-0.26%)
PFE : 30.04 (+1.18%)
TEVA : 9.77 (-0.31%)
RDY : 68.33 (+0.69%)
3 Top-Rated Pharma Stocks Worth Including in Your November Portfolio

The pharmaceutical sector is booming with increasing global healthcare demands and technological progress. Hence, top-rated pharma stocks Dr. Reddy’s (RDY), Novo Nordisk (NVO), and AbbVie (ABBV) might...

ABBV : 138.37 (+0.21%)
NVO : 101.39 (-0.04%)
RDY : 68.33 (+0.69%)
Eli Lilly & Co. (LLY) Earnings Forecast

Drugmaker Eli Lilly and Company (LLY) is scheduled to release its third-quarter results soon. While its revenue is expected to rise sharply over the prior-year quarter, its earnings are expected to decline....

ABBV : 138.37 (+0.21%)
LLY : 588.18 (-0.58%)
RDY : 68.33 (+0.69%)
TARO : 36.31 (+0.78%)
3 Pharma Stocks With Market Impact to Consider Buying

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological...

AMRX : 4.36 (+2.83%)
NVO : 101.39 (-0.04%)
RDY : 68.33 (+0.69%)
3 Pharma Stocks Surpassing Johnson & Johnson (JNJ)

The pharmaceutical sector is anticipated to thrive as demand grows and technology advances. While Johnson & Johnson (JNJ) receives much attention from investors, I believe Horizon Therapeutics Public Limited...

AMGN : 266.39 (+0.33%)
HZNP : 116.30 (+0.04%)
JNJ : 151.53 (-0.07%)
NVS : 96.75 (-0.26%)
RDY : 68.33 (+0.69%)
What Should Pharma Investors Plan to Do With Canopy Growth (CGC) this Month?

Canadian cannabis producer Canopy Growth (CGC) reiterated ongoing concerns about its loss-making status. While the company is making significant efforts to return to profitability, is the stock worth buying...

CGC : 0.5580 (+3.28%)
NVO : 101.39 (-0.04%)
NVS : 96.75 (-0.26%)
RDY : 68.33 (+0.69%)
3 Pharma Stocks to Consider Prescribing to for Quality

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Given the solid long-term prospects of the industry, investors should consider buying quality stocks,...

AZN : 63.87 (+0.90%)
JNJ : 151.53 (-0.07%)
RDY : 68.33 (+0.69%)
3 Pharma Stocks With Promising Pipelines

The pharma industry is anticipated to stay buoyed in the years to come with consistent medical breakthroughs and rising need to serve an aging population. Therefore, pharma stocks Johnson & Johnson (JNJ),...

JNJ : 151.53 (-0.07%)
NVS : 96.75 (-0.26%)
RDY : 68.33 (+0.69%)
Chart of the Day: What's Cooking at Dr. Reddy's Lab

The Chart of the Day belongs to integrated drug company Dr. Reddy's Laboratories (RDY) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy...

RDY : 68.33 (+0.69%)
Top 3 Pharma Stocks You Can’t Miss out On

The ever-transforming pharmaceuticals sector is ready to seize the opportunity to address the growing demand for healthcare across the globe. Therefore, adding these three quality pharma stocks, Johnson...

JNJ : 151.53 (-0.07%)
LLY : 588.18 (-0.58%)
RDY : 68.33 (+0.69%)
SGTX : 22.47 (-2.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through...

See More

Key Turning Points

3rd Resistance Point 68.61
2nd Resistance Point 68.41
1st Resistance Point 68.14
Last Price 68.33
1st Support Level 67.67
2nd Support Level 67.47
3rd Support Level 67.20

See More

52-Week High 73.17
Last Price 68.33
Fibonacci 61.8% 64.74
Fibonacci 50% 62.14
Fibonacci 38.2% 59.54
52-Week Low 51.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar